The story of Viagra and the medicinal industry presents a challenging picture for potential investors. Initially, copyright's remarkable drug transformed the treatment of erectile dysfunction, generating substantial profits and shaping the contemporary pharmaceutical landscape. However, exclusive rights expiration and the appearance of alternative